Preliminary Program...CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7...

CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7 • T: 604-874-4944 F: 604-874-4378 E: [email protected] W: www.cttcanada.org

Preliminary ProgramANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA

2020

Québec City, QCJUNE 22-25, 2020


Preliminary Program2020


ANNUAL CONFERENCE OF CELL THERAPY TRANSPLANT CANADA 2

PRE-CONFERENCE DAY – MONDAY, JUNE 22, 2019 (DELTA HOTELS QUEBEC)Registration

10:30am – 4:00pm

BMT/CT101A: HEALTH CARE PROFESSIONALSOpening Remarks: Donna Wall, MD, Kristjan Paulson, MD The Graft: It Is About the Cells – Nicole Prokopishyn, PhD

Comorbidity Scoring and Fitness – Mahmoud Elsawy, MD, MSc

BMT/CT101B: PATIENTS, FAMILIES, CAREGIVERS*CHAIRS: Lindsay Thompson, Peter MaloneOpening Remarks: Lindsay Thompson, Peter MaloneVision for The Future: Update on Treatment Options – Guy Cantin, MD (TENTATIVE)

Update on Treatment Options for GvHD – Genevieve Gallagher, MD (TENTATIVE)

12:15pm – 1:30pm Lunch

BMT/CT101A: CONTINUES

Decision Process in Preparative Regimen selection – Michael Kennah, MD, MSc

GVHD Prophylaxis Post-HSCT: Are We Over Immunosuppressing? – Jonas Mattsson, MD, PhD

Closing Remarks and Evaluation: Donna Wall, MD, Kristjan Paulson, MD

BMT/CT101B: CONTINUES

Access to New Medication Used in the Treatment of GvHD – Nikki Blosser, BSc. Pharm, ACPR (TENTATIVE)

Closing Remarks: Lindsay Thompson, Peter Malone

2:00pm – 5:00pm CTTC LABORATORY: WET LAB – HÉMA-QUÉBEC4:00pm – 4:30pm Health Break

4:30pm – 7:00pm PATIENT AND CAREGIVER SYMPOSIUM*CHAIRS: Lindsay Thomspon, Peter MaloneRecycling Tools in the Toolbox – Leeza Friedman-Prokopishyn, MSW, RCSW

7:00pm – 8:00pm PATIENT AND CAREGIVER DINNER

6:00pm – 9:00pm PRESIDENTIAL SYMPOSIUM: EVOLVING NATIONAL STRATEGIES FOR CAR-T

DAY 1 – TUESDAY, JUNE 23, 2020 (QUEBEC CITY CONVENTION CENTRE)

7:00am – 8:45am CORPORATE SYMPOSIUM WITH BREAKFAST

Registration

Speaker Services

* simultaneous translations services available






9:00am – 12:15pm SESSION 1: HANS MESSNER LECTURESHIP*CHAIR: Donna Wall, MD and Guy Cantin, MD

Welcome to the Annual Conference – Donna Wall, MD and Guy Cantin, MD

Hans Messner Lectureship: Allogenic Transplants in MDS and High Risk AML – Nicolaus Kröger, MD

Approaches in MDS and AML for Patients Not-Eligible for Transplantation – Julie Bergeron, MD

10:15am – 10:45am Health Break

Hans Messner New Investigator Award 2019: Longitudinal MBW in Pediatric BMT Patient – Jonathan Rayment, MDCM, MSc, FRCP(C)

12:15pm – 1:45pm CORPORATE SYMPOSIUM WITH LUNCH

2:00pm – 5:00pm SESSION 2A: SCIENCE* CHAIR: Frédéric Barabé, MD, FRCPC

Till & McCulloch Lectureship: Guy Sauvageau, MD

SESSION 2B: LABORATORYCHAIR: Diane Fournier, PhD

Advanced Cell Therapies and the Role of Canadian CT Labs – Martin Giroux, PhD

SESSION 2C: NURSING* CHAIR: Stephanie Duguay, IPA, CSIO(C)

How to Inform and Educate Patients (FR) – Sarah-Judith Breton, RN

SESSION 2D: PHARMACY CHAIR: Yves Rousseau, B Pharm, MSc, BCOP

Transplants for SCID and Other Autoimmune Diseases – Esther Jadusingh, BSc, BScPharm, ACPR

3:00pm – 3:30pm Health Break

SESSION 2A: CONTINUES

Mechanisms of Leukemia Immune Evasion and Relapse after Hematopoietic Stem Cell Transplantation – Luca Vago, MD (TENTATIVE)

Gene Therapy for Immune Deficiency – Donald Kohn, MD

SESSION 2B: CONTINUES

Laboratory Nightmares: Past Incidents and Actions to Prevent Future Occurrences – Jelena Holovati, MLT, PhD, and Mike Halpenny, MLT CliniMACs Procedure: Understanding and Optimizing Cell Recoveries – Susan Berrigan, MLT

SESSION 2C: CONTINUES

Complex Pain Management in Pediatric Cell Therapy: IV Dexmedetomidine Outside PICU at CHU Sainte Justine – Julie Paquette RN, MSc and Martine Therrien RN, BSc inf

Out-Patient Transplant Setting: The Role of the Nurse – Laurie Ann Holmes, RN, BScN, CON(C), CHPCN(C)

SESSION 2D: CONTINUES

Access to New Medication Used in the Treatment of GvHD – Nikki Blosser, BSc, BScPharm, ACPR Outpatient Stem Cell Transplant: the Role of the Pharmacist –Philippe Bouchard, BPharm, MSc, BCOP, & Lina Ho, BPharm

5:00pm – 6:00pm WELCOME RECEPTION

6:30pm – 8:00pm CORPORATE SYMPOSIUM WITH DINNER







8:00pm – 9:00pm COMMUNITIES OF PRACTICE: NETWORKING SESSIONS Nursing Networking Session Pharmacist Networking Session Administrators and BMT Coordinators Networking Session Laboratory Networking Session Advanced Practitioners Networking Session

DAY 2 – WEDNESDAY, JUNE 24, 20207:00am – 8:45am CORPORATE SYMPOSIUM WITH BREAKFAST

Registration

Speaker Services

9:00am – 10:00amSESSION 3: FRED SAUNDERS LECTURESHIP* CHAIR: Pierre Teira, MD, MSc

Fred Saunders Lectureship: Gene Therapy For Hemoglinopathy – Marina Cavazzana, MD


10:15am – 11:15am CTTC ANNUAL GENERAL MEETING

11:30am – 1:00pm CORPORATE SYMPOSIUM WITH LUNCH

1:15pm – 3:15pm

SESSION 4: CAR-T AND THE FUTURE OF CELL THERAPY*State of the Nation of CAR-T in Canada – Isabelle Fleury, MD

Advancing Cell Therapies – Cameron Turtle (TENTATIVE)

CAR-NK Cells – Speaker TBD

3:15pm – 3:30pm Health Break

3:30pm – 4:30pm POSTER ABSTRACT PRESENTATIONS

4:30pm – 5:30pm ORAL ABSTRACT PRESENTATIONS ORAL ABSTRACT PRESENTATIONS

7:00pm Onwards GALA DINNER: MUSÉE DE LA CIVILIZATION






Cell Therapy Transplant Canada (CTTC) is pleased to partner with Héma-Québec for Canadian Innovation Day, hosted by the World Marrow Donor Association (WMDA)

DAY 3 – THURSDAY, JUNE 25, 2020: CANADIAN INNOVATION DAYRegistration

Speaker Services

7:00am – 8:30am CORPORATE SYMPOSIUM WITH BREAKFAST

8:45am – 9:55am(Room 200AB)

SESSION 5: FAIR FIGHT FOR ALLIntroduction: Canadian Innovation Day – Jean-Sébastien Delisle, MD, PhD

Swab The World Foundation – Mai Duong & Christiane Rochon First Nations Project (Héma-Québec) – Nadia Baillargeon Panel Discussion and Q&A


10:10am – 11:35am(Room 200A)

SESSION 6: GENE EDITINGCRISPR – Brief History and Current Application – Sylvain Moineau, PhD Blood Stem Cell Genome Editing: CCR5 – Ellie Haddad, MD (Tentative)

Panel Discussion: Ethical Considerations

11:15am – 12:30pm Lunch

12:30am – 2:15pm (Room 200A)

ENABLING INNOVATIONCord Blood Expansion UM171: How will it Affect CBU Selection – Sandra Cohen, MD

Haplo Transplantation: ATIR – Denis-Claude Roy, MD (TENTATIVE)

More than Minimally Manipulated T-Cell Immunotherapies – Jean-Sébastien Delisle, MD, PhD

2:15pm – 2:30pm Health Break (Sponsored by Ontime Courier – Héma-Québec/WMDA)

2:30pm – 5:00pm

ENABLING INNOVATIONTransplantation in MS – Harry Atkins, MD CHUM Innovative Projects – Réjean Lapointe, PhD BioCANRx: Canadian CARs – Kevin Hay, MD (TENTATIVE)

Adoptive Transfer of Plasmacytoid Dendritic Cells to Increase GVL Effect – Michel Duval, MD

6:00pm – 9:00pm CTTC OFFSITE NETWORKING EVENT (LE MONASTÈRE DES AUGUSTINES)

Preliminary Program...CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7...

Documents

Transcript of Preliminary Program...CTTC Head Office: 750 West Pender Street, Suite 301, Vancouver, BC, V6C 2T7...